Albemarle Corporation revised consolidated earnings guidance for the year 2022. Guidance for 2022 revised upward on increased prices in Lithium and Bromine businesses; Net sales are now expected to increase approximately 60%-70% year over year. The company now expects net sales to be in the range of $5.2 billion to $5.6 billion.